IdeaNavigator AI flags a story about a century-old donated kidney as a possible test case for a consumer health and safety monitoring service.
A Century-Old Kidney And The Health Story Behind Its Milestone
Browsing Category
Healthcare operations
34 posts
A Delivery-Type Guide To Postpartum Recovery
An IdeaNavigator AI concept proposes recovery guidance tailored to delivery type, with a pilot measuring use through the six-week postpartum visit.
A Wellness Signal Guide To 5 Digestive Symptoms
IdeaNavigator AI proposes a wellness signal monitor around 5 gastrointestinal symptoms people should not ignore, aimed at fast-moving field operators.
How To Build A Routine For Tracking TRT Labs And Symptoms
IdeaNavigator AI outlines a proposed tracker linking TRT lab results, dose changes and symptoms, with an eight-week test to gauge patient use.
GLP-1 Medications: Find Stock And Compare Cash Prices
A proposed GLP-1 pharmacy index would compare dose availability and cash prices for four brand-name drugs, with a consumer tool and paid data feed.
Building Resilient Remote Teams With Musculoskeletal Strength Assessments
Employers and benefits providers are testing at-home musculoskeletal assessments to prevent remote work-related health issues, with pilot programs underway.
Wellness Signal Monitor: Measles May Have Contributed To Woman’s Death
A Pennsylvania woman who was unvaccinated likely died from measles complications, according to the county coroner. Details are still emerging.
How Benefit Check Bots Support Social Care And Safety-Net Program Outreach
New AI-powered benefit check bots help clinics and nonprofits screen clients for eligibility, addressing unclaimed benefits and streamlining access.
HUTCHMED Announces SANOVO Trial Demonstrated Significant Progression-Free Survival Benefit Of ORPATHYS® Plus TAGRISSO® In Treatment-Naïve Patients With MET-Overexpressing EGFR-mutated Lung Cancer In China
HUTCHMED announces significant progression-free survival improvement in SANOVO trial combining ORPATHYS® and TAGRISSO® for MET-overexpressing EGFR-mutated lung cancer patients in China.
HUTCHMED Announces NMPA Approval For ATLED® (Fanregratinib) For The Treatment Of Patients With FGFR2-Fusion/Rearrangement Intrahepatic Cholangiocarcinoma
HUTCHMED’s ATLED® (Fanregratinib) gains approval from China’s NMPA for intrahepatic cholangiocarcinoma treatment, marking a key regulatory milestone.
